| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |